Edition:
United Kingdom

Strides Pharma Science Ltd (SRID.NS)

SRID.NS on National Stock Exchange of India

497.80INR
21 Sep 2018
Change (% chg)

Rs8.00 (+1.63%)
Prev Close
Rs489.80
Open
Rs499.00
Day's High
Rs510.90
Day's Low
Rs442.50
Volume
3,991,890
Avg. Vol
4,129,854
52-wk High
Rs1,035.00
52-wk Low
Rs333.30

Latest Key Developments (Source: Significant Developments)

Strides Pharma Science Says Unit Got USFDA Nod For Potassium Chloride Extended Release Tablets
Wednesday, 5 Sep 2018 

Sept 5 (Reuters) - Strides Pharma Science Ltd ::STRIDES PHARMA GLOBAL PTE. LTD SINGAPORE GOT USFDA NOD FOR POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS.PRODUCT WILL BE MANUFACTURED AT CO'S FACILITY AT BANGALORE AND MARKETED BY STRIDES PHARMA INC. IN THE US MARKET.  Full Article

Strides Shasun Gets U.S. FDA Approval For Ibuprofen OTC Tablets
Monday, 2 Jul 2018 

July 2 (Reuters) - Strides Shasun Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR IBUPROFEN OTC TABLETS.  Full Article

Strides Shasun Gets USFDA Tentative Approval For Milnacipran Hydrochloride Tablets
Monday, 2 Jul 2018 

July 2 (Reuters) - Strides Shasun Ltd ::SAYS STRIDES SHASUN RECEIVES USFDA TENTATIVE APPROVAL FOR MILNACIPRAN HYDROCHLORIDE TABLETS.  Full Article

Strides Shasun Gets WHO Prequalification for Rectal Artesunate Product
Thursday, 21 Jun 2018 

June 21 (Reuters) - Strides Shasun Ltd ::SAYS CO'S RECTAL ARTESUNATE PRODUCT RECEIVES WHO PREQUALIFICATION.PREQUALIFICATION FOR RECTAL ARTESUNATE SUPPOSITORIES (RAS) FOR PRE-REFERRAL MANAGEMENT OF SEVERE MALARIA.  Full Article

Strides Shasun Appoints Arun Kumar As Group CEO And MD
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::SAYS ARUN KUMAR TO BE GROUP CEO AND MANAGING DIRECTOR OF THE COMPANY .SAYS DEEPAK VAIDYA TO BE THE CHAIRMAN OF THE BOARD OF DIRECTORS OF THE COMPANY.  Full Article

India's Strides Shasun March-Qtr Consol Profit Rises Five-Fold
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::MARCH QUARTER CONSOL NET PROFIT 5.68 BILLION RUPEES VERSUS PROFIT OF 1.12 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 6.64 BILLION RUPEES VERSUS 6.77 BILLION RUPEES LAST YEAR.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets
Wednesday, 2 May 2018 

May 2 (Reuters) - Strides Shasun Ltd ::STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT PUDUCHERRY.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN THE U.S. MARKET.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cyproheptadine Hydrochloride Tablets
Thursday, 12 Apr 2018 

April 12 (Reuters) - Strides Shasun Ltd ::GETS USFDA APPROVAL FOR CYPROHEPTADINE HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN U.S MARKET.SAYS DRUG IS INDICATED TO RELIEVE ALLERGY SYMPTOMS.  Full Article

Strides Shasun Gets U.S. FDA Approval For Efavirenz Tablet
Wednesday, 14 Mar 2018 

March 14 (Reuters) - Strides Shasun Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR EFAVIRENZ TABLET.PRODUCT TO BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE; MARKETED BY STRIDES PHARMA INC IN U.S. MARKET.  Full Article

Strides Shasun Acquires Controlling Stake In Trinity Pharma
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Strides Shasun Ltd ::SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA.UNDER AGREEMENT, STRIDES PHARMA ASIA PTE LTD, SINGAPORE WILL ACQUIRE 55 PERCENT STAKE IN TRINITY FOR 55 MILLION SOUTH AFRICAN RAND‍​.CURRENT MANGEMENT WILL STAY AS MINORITY PARTNER AND RUN THE BUSINESS UNDER SUPERVISION OF STRIDES‍​.  Full Article